Speakers
Marilene Hohmuth Lopes
Associated Professor, Department of Cellular and Developmental Biology, Institute of Biomedical Sciences, USP. Has a doctorate in Oncology from the Antônio Prudente Foundation and a postdoctorate at the Ludwig Institute for Cancer Research. Has experience in Molecular and Cellular Biology focusing on Neuroscience, acting on the following subjects: neurogenesis, embryonic, neural and tumoral stem cells, brain tumors and neurodegenerative diseases.
Flavio Henrique Beraldo de Paiva
Professor at the University of Western Ontario and researcher at Robarts Research Institute. Its main objectives are the understanding of the molecular and cellular mechanisms involved in neurodegenerative diseases such as Prion and Alzheimer and the role of chaperones in embryonic development.
Patrícia Cristina Baleeiro Beltrão-Braga
PhD Professor, Department of Microbiology, Institute of Biomedical Sciences, USP. As a line of research, it investigates the mechanisms of genetic and infectious diseases that affect the CNS, using disease modeling from human iPSC cells, targeting Autism and Congenital Syndrome caused by Zika virus. His group was responsible for proving the causal relationship of Zika virus to microcephaly using brain organoids and animal models.
Maria Rita dos Santos e Passos Bueno
PhD Professor, Department of Genetics, Evolutionary Biology, USP Bioscience Institute. Has experience in the field of Human Genetics and Molecular Genomics, working mainly in research aimed at understanding the genetic mechanisms of the following developmental diseases: Treacher Collins Syndrome and Cleft Palate. He has also been dedicated to studies in the genetics / genomics area of Autism. More recently it has invested in understanding the genetic mechanisms.
Rodrigo Portes Ureshino
PhD Professor, Department of Pharmacology, Federal University of São Paulo (UNIFESP). PhD in Pharmacology from UNIFESP. and postdoctoral at the Federal University of São Paulo (Department of Pharmacology), conducting a research internship at the University of Cambridge at Cambridge. Works in the area of Neuropsychopharmacology, with emphasis on the following subjects: brain aging, neurodegenerative diseases, calcium signaling, apoptosis, autophagy and neuroprotection.
Regina Pekelmann Markus
PhD Professor, Department of General Physiology in USP Bioscience Institute. Acts in the field of chronopharmacology with emphasis on the role of melatonin on inflammatory response and cancer. Proposed the Immune-Pineal Axis, responsible for the alternation between melatonin production by pineal or immunocompetent cells. It is currently developing new molecular platforms of melatonin receptor selective and mixed ligands targeting cancer, overweight and neurodegenerative therapies based on the concept of the Immune-Pineal Axis.
Ana Carolina Thomaz Takakura
PhD Professor, Department of Pharmacology, Institute of Biomedical Sciences, USP. Her main research aims to understand how the Central Nervous System of mammals regulates respiration and blood pressure, identifying important neuronal networks in rodents through electrophysiological and neuroanatomic methods, and the changes observed in these networks in experimental disease models. neurodegenerative disorders, especially Parkinson's disease.
Tatiana Rosado Rosenstock
Associate Professor at Department of Physiological Science at Santa Casa de São Paulo School of Medical Sciences (FCMSCSP) and her research focus is to investigate the relationship between transcription desregulation and mitochondrial dysfunction in different models of neurodegenerative and neuropsychiatric disorders.
Elisa Mitiko Kawamoto
PhD Professor, Department of Pharmacology, Institute of Biomedical Sciences, USP. Works in studies involving hormone, Wnt, Pten, neuronal progenitor cells, synaptic plasticity, inflammation and neurodegeneration. Has experience in Neuropharmacology and Neuroscience, focusing on Biochemical and Molecular Pharmacology, behavior and electrophysiology, acting on the following subjects: Neuroprotection, development, neural stem cells, inflammation, hormones, aging and neurodegeneration
Andréa da Silva Torrão
PhD Professor, Department of Physiology and Biophysics, Institute of Biomedical Sciences, USP. Has experience in Physiology, focusing on Neurophysiology, acting on the following subjects: functional organization of neuromediators systems, regulation of nicotinic and cannabinoid receptors expression, cholinergic and endocannabinoid system, visual pathways and nervous system development, neurodegeneration and neuroprotection.
Merari de Fátima Ramires Ferrari
PhD Professor, Department of Genetics, Evolutionary Biology, USP Bioscience Institute. Has experience in Neurophysiology, Cell Biology and Molecular Biology, acting on the following subjects: nerve cell culture, molecular and cell biology, gene expression analysis, neurodegeneration, cellular communication, mitochondrial transport, intracellular traffic and formation of protein aggregates. Her research line investigates the various stages of intracellular traffic associated with protein aggregation present during neurodegeneration.
Vania Ferreira Prado
Full Professor at the Departments of Anatomy & Cell Biology and Physiology & Pharmacology at the University of Western Ontario and researcher at Robarts Research Institute. Has experience in Pharmacology, focusing on Molecular Neurobiology, acting on the following subjects: neurodegenerative diseases, neurotransmitter transporters, genetically modified mice and expression and purification of toxins with pharmaceutical potential.
Marco Antonio Maximo Prado
Full Professor at the University of Western Ontario and researcher at Robarts Research Institute. Has experience in Pharmacology and Neuroscience, focusing on Biochemical and Molecular Pharmacology, acting on the following subjects: Neurodegenerative diseases, neurotransmitter transporters, confocal microscopy and genetically modified mice.